been severely constrained by the scarcity of high-purity AZAs. Consequently, since their discovery 6 in 1995, considerable efforts have been made to develop methods for isolation of AZAs in sufficient 7 amounts and purities for toxicological studies, in addition to the preparation of reference materials. A 8 7-step procedure was improved for the isolation of AZA1-3, increasing recoveries two-fold 9 compared to previous methods and leading to isolation of sufficiently purified AZA6 for structural 10 determination by NMR spectroscopy. The procedure, which involved a series of partitioning and 11 column chromatography steps, was performed on 500 g of Mytilus edulis hepatopancreas tissue 12 containing ~ 14 mg of AZA1. Overall yields of AZA1 (52%), AZA2 (43%), AZA3 (43%) and AZA6 13 (38%) were good, and purities were confirmed by NMR spectroscopy. The structure of AZA6 was 14 determined by 1-and 2-dimensional NMR spectroscopy and mass spectrometry. The stability of 15 AZA6 relative to AZA1 was also assessed in three solvents in a short-term study that demonstrated 16 greatest stability in aqueous acetonitrile. 17 18
: Structures of AZAs with substitution points for analogues. Note that only AZA1-6 have structures unambiguously established by NMR spectroscopy, while the remaining structures are tentative, base on MS fragmentations, biosynthetic and metabolic considerations, and analogy with known analogues. 139x167mm (300 x 300 DPI) Azaspiracids (AZAs) were discovered after 8 people in the Netherlands became ill in 1995 after 22 consuming mussels harvested off the west coast of Ireland (1). Contaminated mussels from this 23 incident were sent to Tohoku University in Japan, where the primary causative agents (AZA1-3) 24
were isolated and characterized (2, 3). The illness caused by the consumption of AZAs was named 25 azaspiracid shellfish poisoning (AZP), and severe acute symptoms include nausea, vomiting, 26 diarrhea, and stomach cramps (4). The AZA group now includes more than 20 analogues that are 27 either produced by phytoplankton, through biotransformation in shellfish, or as by-products formed 28 as a result of storage of the toxin (5, 6). However, only AZA1-3 are currently regulated by the 29 European Union (7) . The other analogues had initially been found at lower concentrations and were 30 therefore not deemed to be significant, but little is known about these additional analogues and to 31 date only AZA1-5 have been isolated and fully characterized. recently Chile (9-13). The EU has set maximum levels of 160 µg/kg of toxins from the AZA group 37 (defined as the sum of AZA1-3, corrected for their estimated toxic equivalence factors) for shellfish 38 to be placed on the market (7). Until recently, the mouse bioassay (MBA) was the EU reference 39 method for the detection of marine biotoxins in shellfish. However, there were problems with this 40 method in terms of sensitivity, accuracy, false positives and ethics (14) . Although the current 41 regulatory limit for AZAs may be detected by both MBA or LC-MS/MS methods, the MBA is not 42 capable of detecting lower levels and the non-specific character of the assay has prevented its 43 effective use in routine monitoring (15, 16) . The MBA has now been replaced with liquid 44 the ratio of AZA6 to AZA3 was higher in samples from these countries than in profiles observed in 71
European shellfish. 72
73
Isolation of AZAs has been reported previously (3, (30) (31) (32) (33) , however in three of these studies the 74 purity was not assessed by NMR (30-32) and in some cases the recoveries were ambiguously 75 described. In this paper we describe the isolation of AZA1-3 and AZA6 from shellfish using a 76 modified procedure with improved recoveries and purities. This enabled the confirmation, by NMR 77 spectroscopy, of the structure for AZA6 (Figure 1 ) that had previously been proposed based on MS 78 fragmentation studies and analogy with AZA3. We also assess the relative stabilities of AZA1 and 79 AZA6 in three solvents. from Bruckless, Donegal, Ireland, was dissected to yield 500 g of HP, which was homogenized with 110 a Waring blender and freeze-dried (final weight 130 g). The freeze-dried HP was extracted with 111 ethanol (5 × 500 mL) using a Waring blender. The extracts were combined, evaporated in vacuo, and 112 partitioned between ethyl acetate (150 mL) and aqueous NaCl (1 M, 50 mL). The ethyl acetate 113 fraction was evaporated to dryness in vacuo and the oily residue was partitioned between hexane 114 (200 mL) and methanol-water (9:1, 200 mL). The methanolic fraction was evaporated to dryness in 115 vacuo, dissolved in ethyl acetate (20 mL), and ~ 4 g of silica gel was added. The sample was then 116 carefully evaporated to dryness in vacuo, mixed to a fine powder and loaded onto a silica gel (55 g) 117 column (19.5 × 5 cm). Vacuum assisted elution was performed successively with hexane, ethyl 118 acetate, ethyl acetate-methanol (9:1), (7:3), (1:1), and methanol (300 mL of each, all containing 119 0.1% acetic acid except for hexane). The 7:3 ethyl acetate-methanol fraction which FIA-MS/MS 120 (Method C) showed to contain the AZAs, was evaporated in vacuo, loaded in MeOH onto a 121 Sephadex LH-20 column (150 × 1.5 cm, packed in MeOH) and eluted by gravity (~ 1 mL/min) with 122 methanol. The first 20 min of eluate was collected separately, with 3-min fractions collected 123 thereafter. Fractions containing AZAs (fractions 8-15), as determined by FIA-MS/MS, were 124 combined, evaporated to dryness in vacuo, and the sample loaded in acetonitrile-water (6:4, plus 125 0.1% triethylamine) onto a column packed with Phenyl-Hexyl (19.9 × 2 cm). The sample was eluted 126 with acetonitrile-water (3:7, plus 0.1% triethylamine) at 4 mL/min, and 5 mL fractions were 127 collected. Appropriate fractions were combined (AZA3, fractions 10-15; AZA6, fractions 16-23; 128 AZA1, fractions 24-34 and AZA2, fractions 35-45) based on FIA-MS/MS analysis. 129
Final purification of AZA1 was achieved by semi-preparative LC (Agilent 1200) with photodiode 130 array (PDA) detection (210 nm) using a Luna C8 (5 µm, 250 × 10 mm, Phenomenex) column eluted 131 8 with acetonitrile-water (1:1, plus 2 mM ammonium acetate) at 4 mL/min. The column temperature 132 was 30 °C. AZA2, AZA3 and AZA6 were purified using the same system as for AZA1, but with a 133 narrower-bore column (Cosmosil C18, 5µm, 250 × 4.6 mm, Nacalai tesque) eluted with acetonitrile-134 water (1:1, plus 2 mM ammonium acetate) at 1 mL/min. Purified AZAs were recovered by diluting 135 the fractions with water (to 20% acetonitrile), loading on to solid-phase extraction (SPE) cartridges 136 (Oasis HLB, 200 mg), washing with methanol-water (1:9, 10 mL) to remove the buffer and eluting 137 with methanol-water (9:1, 20 mL). Waters 2795 LC by running MS scans (m/z 100-1000) using the same chromatographic conditions 161 as above. Identification of other contaminant AZA analogues was also determined by performing 162 product ion scans, where the precursor ions were selected and then fragmented, for all the known 163 AZA analogues (Table 1) . 164
Method C. Qualitative analysis of fractions for AZAs was performed by FIA-MS/MS using a 165
Micromass QTof Ultima coupled to a Waters 2795 LC. Samples (2 µL) were injected, using the 166 2795 autosampler, directly (no column) into the mass spectrometer monitoring for the precursor ions. 167
168

LC-PDA purity analysis. 169
Method D. A concentrated sample (~ 500 µg/mL) was injected (1 µL) onto the semi preparative 170 system (Shimadzu 10AVp) with photodiode array (PDA) detection (210 nm) using a Cosmosil C18 171 column, 5 µm, 250 × 4.6 mm eluted with acetonitrile-water (1:1, plus 2 mM ammonium acetate) at 1 172 mL/min. The column temperature was 30 °C. 173
174
Method E. An additional method employed to detect any strongly retained compounds (e.g. 175 phthalates) used an analytical LC system (Shimadzu LC 10AVp) with PDA detection at 210 nm. The 176 sample collected after the SPE step was injected (5 µL) onto a Vydac C18, column (10 µm, 250 × 177 4.6 mm, Grace) and eluted with methanol-water (9:1) at 1 mL/min, maintaining the column 178 temperature at 30 °C. 179 180 NMR Spectroscopy. NMR-purity was assessed by 1 H NMR using a Bruker DRX-500 spectrometer. 181
The structure of AZA6 was determined by analysis of 1 H, COSY, TOCSY, NOESY, ROESY, HSQC 182
and HMBC spectra using a Bruker Avance III 700 spectrometer fitted with a 1.7 mm proton-detect 183 micro-cryoprobe. Approximately 50 µg of AZA6 was dissolved in 30 µL CD 3 OH, and proton-184 detected spectra were acquired with pre-saturation of the OH peak The TOCSY spectrum was 185 recorded using an MLEV sequence with a 120 ms mixing time. The ROESY spectrum was acquired 186 with a spin-lock pulse of 200 ms and a spin-lock field of approximately 3 kHz. Two HMBC spectra 187 were recorded, optimized for long-range couplings of 8.33 Hz and 5.56 Hz (60 ms and 90 ms 188 evolution times, respectively). All samples were tuned and matched to 50 Ω resistive impedance. freeze-dried HP sample resulting in a 95% clean up (Table 1) . Small scale tests with methanol and 218 ethanol as extraction solvents showed that both solvents were equivalent in terms of extraction 219 efficiency. Ethanol was chosen as the extraction solvent primarily to minimize the formation of side 220 products, which can be significant when methanol is used as extractant (5), and also because it is a 221 less toxic solvent. 222
Freeze-drying of shellfish prior to extraction has been successfully employed previously in the 223 isolation of pinnatoxins from Australian oysters (35). This has many advantages, including avoiding 224 the necessity of using water-miscible extraction solvents, complete control of extractant composition, 225
and low water content in the extract (thus avoiding difficulties during evaporation and potentially 226 toxin stability problems). The effect of freeze-drying the mussel HP prior to extraction of AZAs was 227 therefore explored. Higher extraction efficiencies were achieved for the freeze-dried samples after 228 the first and second extractions with 12% and 2% more AZAs being extracted respectively. No 229 difference was observed in clean up efficiency (94.2% for both freeze-dried and wet tissues), but the 230 extracts from the freeze-dried samples evaporated more quickly with little or no foaming in the 231 subsequent vacuum-evaporation step. The two subsequent liquid-liquid partitioning steps resulted in 232 only minor losses of toxin (~ 95% recovery) with an overall clean up efficiency of 67% (Table 1) . 233 234 Silica gel (step 4). The sample was eluted from the silica gel column with step gradients of hexane, 235 ethyl acetate, ethyl acetate-methanol and methanol. AZAs eluted in 7:3 ethyl acetate-methanol, with 236 only small losses of toxin. The ethyl acetate-methanol mixtures contained 0.1% acetic acid. Previous 237 studies have shown that AZAs are unstable in acidic environments, but that shellfish tissue appears 238 to have a protective effect (36). As the sample at this stage of the isolation was still quite crude, and 239 there appeared to be no degradation of the AZAs during small-scale trials, it was deemed to be safe 240 to use acetic acid in the eluent at this point of the procedure. Attempts to replace the acetic acid with 241 0.1% triethylamine were unsuccessful, with the toxins eluting over three of the mobile-phase 242 compositions, thereby reducing the clean-up efficiency significantly. Of all the steps in the 243 procedure, silica gel chromatography (step 4) gave the greatest efficiency in terms of clean up (93%) 244 and recovery (~ 95%) ( Table 1) efficiency and recovery however, with respect to resolution, the Phenyl-Hexyl proved to be much 258 more efficient at separating the AZA analogues than the RP-8 stationary phase (Table 2) . Separation 259 of the AZA analogues at this stage in the procedure improved recoveries and purities in the final 260 semi-preparative LC step (step 7), so the Phenyl-Hexyl stationary phase was chosen as the stationary 261 phase for flash chromatography. This step resulted in a clean-up of 64% (assessed after the RP-8 vs 262
Phenyl-Hexyl experiment, see Materials and Methods section) and a recovery of ~ 90% (Table 1) . 263
264
Prep HPLC (step 7). An acidic mobile phase was used for semi-preparative LC purification in 265 preliminary studies, but AZAs were very unstable when evaporated to dryness from the acidic eluent 266 (unpublished information). Therefore, a neutral mobile phase was chosen to prevent AZA 267 degradation. Acceptable chromatography was obtained for AZA1 and AZA2 using the neutral 268 mobile phase, but broad, fronting peaks were observed for AZA3 and AZA6. Similar 269 chromatography for AZA3 was also observed using alkaline conditions on an analytical scale (37). 270 This is presumably related to the fact that both AZA3 and AZA6 lack a methyl group at the R 3 271 position ( Figure 1 ) which somehow affects their chromatographic behavior. All fractions were 272 collected based on UV detection at 210 nm to minimize contamination with non-AZA analytes. 273
Most (80%) of the AZA6 from the flash chromatography (step 6) was recovered in the AZA6 274 fraction, and 20% came from the AZA3 fraction. The recovery of AZA6 from the semi-preparative 275 LC (61%) was slightly less than for the other AZA analogues (all ~ 85%), probably because co-276 eluting compounds necessitated significant heart cutting. 277 278 SPE recovery of AZAs from eluent. Fractions from the semi-preparative LC purification were 279 diluted with water and recovered on SPE cartridges in order to remove any buffer remaining in the 280 sample, but also to reduce the water content in, and volume of, the AZA fractions prior to 281 evaporation, and as an additional final clean-up step to remove trace contaminants introduced via the 282 LC eluents. This SPE recovery resulted in very little loss of toxin, with recoveries of >95% being 283 achieved, and greatly facilitated evaporation of the purified AZA-fractions to dryness. 284
285
Overall recoveries. 7.3 mg of AZA1 was purified along with 1.6 mg of AZA2, 2.0 mg of AZA3 and 286 300 µg of AZA6. Overall recoveries (steps 1-7) were 52% for AZA1, 43% for AZA2 and -3, and 287 38% for AZA6, and represent a two-fold increase in recovery compared to previous isolations 288 carried out as part of the ASTOX project (33, 38) . Furthermore, the improved procedure is 289 significantly easier to perform and less labor intensive. 290
spectrometry. An LC-MS scan was performed in the range m/z 100-1000, followed by LC-MS/MS 293 analysis for all the known AZA analogues as well as for any additional masses picked up in the MS 294 scan (Method B). The sample was also analyzed using the LC-PDA semi-preparative method 295 (Method D) to ensure that no additional peaks were observed in the UV trace. To determine whether 296 strongly retained compounds, such as phthalates, were present in the sample, isocratic LC-PDA was 297 performed (Method E). Previous NMR analysis had shown the presence of a phthalate in some 298 fractions which was detectable by LC-PDA (λ max 205, 225 and 275 nm). This contaminant was 299 conveniently removed by partitioning with hexane. Once samples were deemed to be sufficiently 300 pure (LC-MS/MS and LC-PDA), they were prepared for NMR spectroscopy. The 1 H NMR spectra 301 of AZA1-3 were compared to published NMR data and found to be essentially identical, and 302 examination of the spectra indicated purities of >95%. 303 304 AZA6 structural elucidation by NMR spectroscopy. NMR data for AZA6 have not been 305 published, and its proposed structure was based only on MS/MS fragmentation and on analogy with 306 the structure of AZA3. AZA6 was therefore subjected to a more thorough series of 1-and 2D NMR 307 experiments to verify its presumed structure. 308 NMR analysis confirmed the previously postulated structure of AZA6, a methyl group at the R 2 309 position (C-8) and a methylene at C-22 (R 3 = H), see Figure 1 and Table 4 . Structural elucidation of 310 AZA-6 was done using 1-and 2-dimensional homonuclear 1 with published data for AZA-1, -2 and -3 (2, 3). One-dimensional 1 H NMR and edited HSQC spectra 313
showed that AZA6 had 6 methyl, 16 methylene, and 17 methine groups. Chemical shifts for eight 314 quaternary carbons were ascertained from HMBC correlations (2.20,2.31/181.6, C-1; 315 5.71,5.32/72.29, C-6; 1.67,1.96/130.8, C-8; 1.93,0.91/106.9, C-10; 1.93,0.91/110.9, C-13; 2.13/98.1, 316 C-21; 3.93/146.6, C-26; 2.14/97.6, C-28; and 0.83/95.6, C-36). Chemical shifts reported in Table 4  317 are from the HSQC (for 1 H and protonated 13 C atoms) and HMBC (for quaternary carbon atoms) 318 spectra. 319 320 Analysis of the COSY and TOCSY spectra led to the identification of 9 spin-systems based on 321 protons and methyl groups attached to C-2-C-7; 8-CH 3 ; C-9; C-11-C-12; C-14-C-20; C-22-C-25; 322 26=CH 2 ; C-27; C-29-C-35; and C-37-C-40. The following HMBC correlations defined the 323 connections of the spin systems: C-6 to H-7; C-7 to 8-CH 3 ; C-8 to 8-CH 3 and H-9a,b; C-9 to 8-324 CH 3 ; C-10 to H-9; C-10 to H-11b; C-13 to H-12b; C-13 to H-14; C-13 to 14-CH 3 ; C-21 to H-22a,b; 325 C-25 to 26=CH 2 ; 26=CH2 to H-27b; C-26 to H-27a,b; C-28 to H-27a,b; C-38 to 37-CH 3 ; and C-36 326 In summary, a method was optimized for the isolation of AZAs from highly contaminated M. edulis 391 HP. A seven-step procedure involving extraction, two partitioning, and four chromatography steps 392 was employed. The method was adapted to limit degradation of sample by replacing acidic mobile 393 phases with slightly basic and neutral mobile phases in two of the chromatography steps. Improved 394 separation of the AZAs during the penultimate step (flash chromatography; step 6) was achieved by 395 preparative LC. Overall recoveries of ~ 40-50% were achieved for AZA1-3 and AZA6. Sufficient 397 AZA6 was isolated for structural elucidation by NMR which confirmed the previously postulated 398 structure (Figure 1) . A short-term stability study showed that AZA6 is significantly more stable in 399 aqueous acetonitrile than in methanol (the usual storage solvent) at 40 °C. The isolated AZAs are of 400 sufficient purity for toxicological research and for the preparation of analytical standards. Table 1 . Batch summary table for purification of AZA1-3 and AZA6.
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